Research of Tolvaptan prescription in SIADH patients (Observational research using DPC)

Research of Tolvaptan prescription in SIADH patients (Observational research using DPC) - Research of Tolvaptan prescription in SIADH patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046985

Enrollment

2800

Registered

2022-03-01

Start date

2022-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SIADH

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with a diagnosis of "ICD10E222: Syndrome of inappropriate secretion of antidiuretic hormone <SIADH>" during the enrollment period

Exclusion criteria

Exclusion criteria: - Patients under 18 years old

Design outcomes

Primary

Measure	Time frame
-Tolvaptan prescription in actual clinical practice (starting dose, increase / decrease, prescription period, re-administration) - Changes in serum sodium concentration, occurrence of rapid correction of hyponatremia (by Tolvaptan dose)	—

Secondary

Measure	Time frame
-Patient demographic and clinical characteristics	—

Countries

Japan

Contacts

Public ContactMiyuki Matsukawa

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

Matsukawa.miyuki@otsuka.jp080-6791-7646

Outcome results